Yet another new type of HIFU is now in Phase II clinical trials

Another breathless media release has announced enrollment of the first patient into a Phase II clinical trial of yet another new form of high-intensity, focused ultrasound (HIFU) in men with low-risk and favorable, intermediate-risk, localized prostate cancer. … READ MORE …

Pfizer to buy Medivation (developer of Xtandi)

According to news this morning, Pfizer has entered into a merger agreement which will allow the company to buy Medivation (the developer of enzalutamide, also known as Xtandi). Rumors had been rife since last Friday. … READ MORE …

Howard Wolinsky’s continuing journey

Howard Wolinsky is a professional journalist who is being managed on active surveillance for a low-risk form of prostate cancer. He writes about this for MedPage Today. … READ MORE …

Is ADT giving you Alzheimer’s disease? … Another look

Late last year we reported on a study in the Journal of Clinical Oncology that suggested the possibility of a link between androgen deprivation therapy (ADT) and the onset of Alzheimer’s disease. … READ MORE …

For very high-risk patients, EBRT + BT is superior to surgery or EBRT only

A retrospective analysis of oncological outcomes among modern-era patients with a Gleason score of 9 or 10 demonstrates a clear advantage to a combination of external beam radiation therapy (EBRT) with a brachytherapy (BT) boost to the prostate and short–term androgen deprivation therapy (ADT). … READ MORE …

Tales from “a poster boy” for active surveillance

Howard Wolinksy is  a journalist — by training and by profession. In 2010, a while after he finished full-time employment with the Chicago Sun-Times, he was diagnosed with low-risk prostate cancer, and he has been documenting the impact ever since. … READ MORE …

First data from a RTC of proton beam radiation vs. conventional radiation therapy

When you go to large meetings with thousands of presentations, you miss things. And here’s one that a lot of people seem to have missed — your sitemaster included. … READ MORE …